Health Care [ 9/12 ] | Pharmaceuticals [ 38/74 ]
NASDAQ | Common Stock
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels.
The company was incorporated in 2012 and is headquartered in Newport Beach, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 5, 25 | -0.24 Decreased by -50.00% | -0.15 Decreased by -60.00% |
| Aug 5, 25 | -0.27 Decreased by -575.00% | -0.10 Decreased by -170.00% |
| May 5, 25 | -0.17 Decreased by -88.89% | -0.10 Decreased by -70.00% |
| Mar 4, 25 | 0.01 Increased by +111.58% | 0.02 Decreased by -37.67% |
| Nov 6, 24 | -0.16 Increased by 0.00% | -0.10 Decreased by -60.00% |
| Jul 31, 24 | -0.04 Increased by +78.95% | -0.05 Increased by +20.00% |
| May 7, 24 | -0.09 Increased by +40.00% | -0.10 Increased by +10.00% |
| Mar 7, 24 | -0.12 Increased by +14.29% | -0.07 Decreased by -71.43% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 68.97 M Increased by +12.90% | -15.74 M Increased by +17.91% | Decreased by -22.82% Increased by +27.29% |
| Jun 30, 25 | 69.39 M Increased by +3.70% | -17.14 M Decreased by -51.03% | Decreased by -24.70% Decreased by -45.64% |
| Mar 31, 25 | 68.52 M Increased by +15.49% | -18.89 M Decreased by -44.11% | Decreased by -27.57% Decreased by -24.79% |
| Dec 31, 24 | 78.95 M Increased by +29.42% | -6.79 M Increased by +42.60% | Decreased by -8.60% Increased by +55.65% |
| Sep 30, 24 | 61.09 M Increased by +22.12% | -19.17 M Decreased by -13.28% | Decreased by -31.38% Increased by +7.24% |
| Jun 30, 24 | 66.91 M Increased by +35.59% | -11.35 M Increased by +37.43% | Decreased by -16.96% Increased by +53.85% |
| Mar 31, 24 | 59.33 M Increased by +42.21% | -13.11 M Increased by +11.37% | Decreased by -22.09% Increased by +37.68% |
| Dec 31, 23 | 61.00 M Increased by +39.76% | -11.83 M Increased by +10.13% | Decreased by -19.40% Increased by +35.69% |